[Oncologic training of nurses--objectives and program].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to M Pawlicki.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Own concept of small cell lung carcinoma (SCLC) chemotherapy with multidrug regimen including ifosfamide, adriamycin, and etoposide is presented. In the pilot trial, 67% of remissions in patients with localized, and 33% in patients with disseminated neoplastic process were achieved. Proposed therapy has moderate toxicity, markedly lower than that of the regimen including cis-platin. No nephrotoxicity is worth emphasizing. The authors suggest that proposed regimen may be of value in patients in whom combined chemo- and radiotherapy is foreseen.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
An analysis of factors producing advanced small cell lung cancer in 57 patients from the Chemotherapy Department of the Oncological Center in Cracow. The main reason for delay in chemotherapy in small cell lung cancer were diagnostic mistakes. Almost 40% of the patients were treated with improper diagnoses for a mean period of 6 months. Although 28.3% seeked non-medical help this did not effect nor delay chemotherapy.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.